# DESCRIPTION

## TECHNICAL FIELD

- relate to gene therapy drug for granular corneal degeneration

## BACKGROUND ART

- describe corneal degeneration and its treatment methods

## SUMMARY

### Technical Problem

- identify the need for a novel approach to treat granular corneal dystrophy

### Solution to Problem

- describe the need for gene repair
- introduce genome editing technology using CRISPR/Cas9
- explain the design of gRNA and HDR template donor
- describe the method of treating granular corneal degeneration
- outline the advantages of the invention
- summarize the invention

### Advantageous Effects of Invention

- highlight the benefits of the invention

## DESCRIPTION OF EMBODIMENTS

- introduce treatment method for granular corneal degeneration
- describe TGFBI gene mutations causing granular corneal degeneration
- explain RNA-guided CRISPR/Cas9 genome editing technology
- describe design of gRNA for targeting TGFBI gene mutations
- outline method for delivering Cas protein and gRNA into keratocytes
- explain homology directed repair (HDR) for repairing TGFBI gene mutations
- describe design of donor DNA for HDR

### EXAMPLES

- design and test gRNA and HDR template donor for treating granular corneal degeneration
- confirm genome editing efficiency using RFLP and gene sequence analyses

